Integra Lifesciences PE ratio IART
Share price divided by earnings per share over the last twelve months, since 2011.
- Today, Nov 2, 2026
- 80.1×
- 10-year median
- 46.3×
- Against its 10-year history
- 84th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 18.7× to 179×
- Peer median
- 28.3×
Integra Lifesciences' PE ratio is 80.1× as of Nov 2, 2026: a share price of $13.61 against $0.17 of earnings per share over the last twelve months.
That is above its ten-year median of 46.3×, higher than on 84% of days in the last ten years.
Over that time it ranged from 18.7× in May 2023 to 179× in Jun 2020.
The median for 10 medical instruments and supplies stocks of a similar size is 28.3×.
PE ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 80.1× | 75.0× | 80.1× |
| 2025 | n/m a value too high to mean anything | ||
| 2024 | 66.5× | 33.2× | 82.9× |
| 2023 | 36.0× | 18.7× | 36.9× |
| 2022 | 27.2× | 21.4× | 34.1× |
| 2021 | 26.4× | 24.7× | 103× |
| 2020 | 96.9× | 65.2× | 179× |
| 2019 | 85.0× | 44.8× | 90.2× |
| 2018 | 44.8× | 44.8× | 88.6× |
| 2017 | 78.5× | 34.3× | 82.8× |
| 2016 | 42.5× | 37.5× | 42.5× |
| 2015 | 48.8× | 46.4× | 61.4× |
| 2014 | 58.0× | 50.6× | 58.0× |
| 2013 | 49.3× | 22.6× | 50.0× |
| 2012 | 33.3× | 17.2× | 48.5× |
| 2011 | 21.7× | 20.4× | 26.5× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Integra Lifesciences' size, closest first, today.
| Company | PE ratio |
|---|---|
| IARTIntegra Lifesciences | 80.1× |
| IRMDIradimed | 42.5× |
| BVSBioventus | 17.1× |
| STAAStaar Surgical | 356× |
| CDRECadre | 38.9× |
| EYENational Vision | 28.1× |
| MOVMovado | 17.7× |
| LMATLemaitre Vascular | 28.5× |
| INSPInspire Medical Systems | 14.5× |
| TCMDTactile Systems Technology | 21.2× |
| UFPTUFP Technologies | 30.6× |
| Peer median | 28.3× |
Where Integra Lifesciences ranks
What the PE ratio tells you
Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.
Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.
More on Integra Lifesciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.